A Study of Ruxolitinib in Combination With Abemaciclib for the Treatment of Myelofibrosis

Abroad (travel likely)RecruitingPHASE1

Conditions

Myelofibrosis Due to and Following Polycythemia Vera

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

    Contact: Study coordinator (Raajit Rampal, MD,PhD) · 646-608-3746
  • Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States

    Contact: Study coordinator (Raajit Rampal, MD, PhD) · 646-608-3746
  • Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States

    Contact: Study coordinator (Raajit Rampal, MD, PhD) · 646-608-3746
  • Memorial Sloan Kettering Suffolk - Commack, Commack, New York, United States

    Contact: Study coordinator (Raajit Rampa, MD, PhD) · 646-608-3746
  • Memorial Sloan Kettering Westchester, Harrison, New York, United States

    Contact: Study coordinator (Raajit Rampal, MD, PhD) · 646-608-3746
  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

    Contact: Study coordinator (Raajit Rampal, MD, PhD) · 646-608-3746
  • Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States

    Contact: Study coordinator (Raajit Rampal, MD, PhD) · 646-608-3746
Study leads
  • Raajit Rampal

    Principal Investigator

    Memorial Sloan Kettering Cancer Center